Open Access4cps-009 efficacy, safety and economic impact of vedolizumab in ulcerative colitis and crohn’s disease
Author(s) -
J Preciado Goldaracena,
J Polo García,
JA Illodo Becerra,
M Coma Punset,
I Monteserin Garrastatxu,
M De Miguel Gaztelu,
J Fernández González,
A Agulló Fenoll,
G Pinilla Lebrero,
ME Carrasco del Amo,
M Sarobe Carricas
Publication year - 2018
Publication title -
section 4: clinical pharmacy services
Language(s) - English
Resource type - Conference proceedings
DOI - 10.1136/ejhpharm-2018-eahpconf.100
Subject(s) - vedolizumab , medicine , ulcerative colitis , infliximab , adverse effect , crohn's disease , gastroenterology , inflammatory bowel disease , adalimumab , retrospective cohort study , disease
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom